Immune-mediated polyarthritis (IMPA) is a common orthopaedic presenting condition but can affect many body systems giving rise to numerous clinical presentations. Even once IMPA has been diagnosed, there is the challenge of deciding if this is a primary autoimmune disease or a consequence of another focus of inflammation requiring identification. Treatment can vary and relapse is common, and deciding on the best treatment option can be a difficult process
This lecture will address these questions and the clinical decision making with the evidence (or lack thereof!) behind them.
Language: English
Recorded on February 19, 2026.
1 hour according to § 10(2) of the ATF Statutes as mandatory continuing education for ATF members.
ATF hours are recognized by the ÖTK as educational hours.
Recognition according to the guidelines of the Society of Swiss Veterinarians is possible.
The accreditation of CE Points is approved under the condition of a positive completion of the test in the specified period and is valid from February 19, 2026 - February 19, 2027
Speaker:
Craig Breheny
BVM&S, DipECVIM-CA, SFHEA, MRCVS
Craig spends most of his time in the Emergency & Critical Care department, where he is co-head. His main interests are immune-mediated conditions, and IMPA in particular.
